45.23
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat
Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail
Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily
Collegium Pharmaceutical Closes New $980 Million Credit Facility - TipRanks
Collegium Pharmaceutical Closes $980 Million Syndicated Credit Facility - marketscreener.com
Collegium Pharmaceutical Signs Credit Agreement With Truist Bank - TradingView — Track All Markets
Collegium Pharmaceutical, Inc. Announces the Closing of $980 Million Syndicated Credit Facility - marketscreener.com
Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
2 Reasons to Avoid COLL and 1 Stock to Buy Instead - Yahoo Finance
Collegium Pharmaceutical stock hits all-time high at 49.92 USD By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighStill a Buy? - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.92 USD - Investing.com India
Is Collegium Pharmaceutical Inc a good long term investmentMarket Rumors and News & High Yield Trading Plans - earlytimes.in
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - sharewise.com
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Assenagon Asset Management S.A. Purchases 92,898 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthTrade Entry Summary & Daily Profit Maximizing Trade Tips - bolumsonucanavari.com
Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesInsider Buying & Advanced Technical Analysis Signals - Улправда
How rising interest rates impact Collegium Pharmaceutical Inc. stockWeekly Investment Report & Safe Capital Investment Plans - Улправда
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? - Yahoo Finance
Can Collegium Pharmaceutical Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - Улправда
Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily
Published on: 2025-12-19 17:44:17 - DonanımHaber
Is Collegium Pharmaceutical Inc. stock positioned for digital transformationJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
3 Unpopular Stocks We Find Risky - Finviz
Will Collegium Pharmaceutical Inc. stock deliver strong dividend growthMarket Volume Report & Comprehensive Market Scan Reports - DonanımHaber
Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingJuly 2025 Sentiment & High Conviction Investment Ideas - DonanımHaber
How Collegium Pharmaceutical Inc. stock performs in weak economy - Улправда
Trade Recap: Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spending2025 Support & Resistance & Reliable Intraday Trade Plans - DonanımHaber
Collegium Pharmaceutical Earnings Notes - Trefis
Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketJuly 2025 Movers & Long Hold Capital Preservation Tips - Улправда
Best Value Stocks to Buy for Dec. 18 - sharewise.com
Strong Q3 Beat and Guidance Upside Might Change The Case For Investing In Collegium Pharmaceutical (COLL) - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - 富途牛牛
Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance - simplywall.st
Collegium Pharma spikes after 2025 outlook - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year HighShould You Buy? - MarketBeat
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Collegium Pharmaceutical Inc 354 Stock Analysis and ForecastMarket Volatility Update & Exceptional Return Growth - earlytimes.in
Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 17,600 Shares of Stock - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.11 USD By Investing.com - Investing.com Canada
Collegium Pharmaceutical stock hits all-time high at 49.11 USD - Investing.com
1 Growth Stock Set to Flourishand 2 Facing Challenges - The Globe and Mail
Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com India
Collegium pharmaceutical EVP Dreyer sells $847k in stock By Investing.com - Investing.com Australia
大文字化:
|
ボリューム (24 時間):